Nandini Piramal is the Executive Director of Piramal Enterprises Limited and leads the Over-The-Counter (OTC) business of the company. Under Nandini’s leadership, the OTC business has emerged as one of the fastest growing Indian OTC companies with most its brands ranked No.1 or No.2 in their respective markets and product categories. She played a pivotal role in Piramal Healthcare’s branded generic-medicine business sale to Abbott Laboratories, at a record 30x EBITDA.
Nandini heads the Human Resources and Information Technology functions at Piramal Group and the Quality & Risk functions for the Pharma business. She has recently initiated an HR transformation strategy, with renewed focus on service delivery, customer centricity and operational excellence.
Nandini has been recognized amongst India’s Most Powerful Women by Business Today (2020), and as a ‘Young Global Leader’ by the World Economic Forum (2014).
Nandini is passionately involved with Piramal Foundation (the philanthropic arm of the Piramal Group), and its initiatives: Piramal Swasthya, Piramal School of Leadership and Piramal Sarvajal.
She holds a Master’s Degree in Business Administration from Stanford Graduate School of Business and a Bachelor’s Degree (Hons.) in Politics, Philosophy and Economics from Oxford University.
Chairman, Piramal Group
Vice Chairperson, Piramal Group
Executive Director, Piramal Group
Non-Executive Director, Piramal Enterprises Ltd.
Managing Director, India Resurgence Fund (IndiaRF)
Group Director - Strategic Business
CEO, Piramal Foundation
MD, Piramal Capital & Housing Finance Limited (PCHFL)
CEO, Piramal Alternatives
Group President, Piramal Enterprises Limited
Chief Executive Officer, Wholesale Lending, Piramal Capital & Housing Finance Ltd (PCHFL)
Group General Counsel, Piramal Group
President & Group CIO, Piramal Group
President & Chief Human Resources Officer, Piramal Group
CFO, Piramal Enterprises Limited (PEL)